| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |